Players in Veterinary Molecular Diagnostic Market Finding Rich Opportunities in the U.S.

Published Date : Jun 06, 2018

ALBANY, New York, June 6, 2018 – The prestigious repository of business intelligence reports at now announces the availability of another high quality commerce study on the market for veterinary molecular diagnostics. Developed by an experienced and professional research analyst, this report has projected that the demand in the global veterinary molecular diagnostics market will expand at a notable CAGR of 8.6% during the forecast period of 2017 to 2025. The report, titled “Veterinary Molecular Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017-2025,” has estimated that the opportunities in this market will translate into a revenue of US$792.5 million, swelling up from its evaluated worth of US$377.2 million as of 2016.

The study is a summation of figurative evaluations and estimations on the profitability of the veterinary molecular diagnostics market. Compiled using proven market research methodologies and under the guidance of experts of the industry, the report aspires to aid in critical business decision making of its targeted audiences such as manufacturers of veterinary diagnostic equipment, research and development companies, government agencies, and venture capitalists and investors. The report includes chapters: executive summary to briefly highlight market’s key aspects, segments it on the basis of product, technology, animal type, disease indication, and end users, and examines potential of demand that can be expected out of various important countries and regions.

For Sample Copy, click here:  

On the basis of product type, this report bifurcates the veterinary molecular diagnostics market into kits & reagents, instruments & software, and services. Technology-wise, the market has been categorized into DNA sequencing, microarrays, and polymerase chain reaction (PCR). On the basis of disease indication, the analyst of this report has classified the veterinay molecular diagnostics market into respiratory pathogens detection, vector-borne diseases, and diarrhea pathogens detection. The report also has evaluated and represented the potential of demand that will be coming during 2017 to 2025 from the end users of reference laboratories and hospitals and clinics. Currently, the reference laboratories segment is dominating the market in terms of volume of demand.

Region-wise, North America dominated the demand in 2016 and is expected to remain the dominant region across the world until 2025. The developed country of the U.S. is the leader in terms of research and development laboratories, gaining traction from government and private funding. A large volume of tests are performed by key players in this country such as Thermo Fisher, Idexx, and VCA. Following North America is Europe, which again houses a few developed countries. High adoption of veterinary diagnostics, drugs, vaccines, and medicated feed additives for the well-being of rapidly increasing population of livestock animals in the region makes Asia Pacific one of the most lucrative markets for veterinary molecular diagnostics.

The report profiles a number of key players, such as Thermo Fisher Scientific, Inc., Novacyt Group, VCA, Inc., IDEXX Laboratories, Inc., QIAGEN N.V., HealthGene Corporation, Biomedica Medizinprodukte GmbH & Co KG, and Bioneer.

To order report Call Toll Free: 866-997-4948 or send an email on